Navigation Links
Essilor's First-Half 2008 Results
Date:8/27/2008

/> http://hosting.3sens.com/Essilor/20080828-379EA2FD/en

The presentation will be posted at the following address:

http://www.essilor.com/results-presentations

Regulatory Information The interim report can be downloaded from the Company's website, http://www.essilor.com, in the News > Publications section, or by clicking on: http://www.essilor.com/reports#interim

------------------------

Next financial announcement:

Third-quarter revenue will be announced on Thursday, October 23, 2008.

------------------------

Essilor International is the world leader in ophthalmic optical products, offering a wide range of lenses under the flagship Varilux(R), Crizal(R), Essilor(R) and Definity(R) brands to correct myopia, hyperopia, presbyopia and astigmatism. Essilor operates worldwide through 15 production sites, 270 lens finishing laboratories and local distribution networks. The Essilor share trades on the Euronext Paris market and is included in the CAC 40 index. Codes and symbols: ISIN: FR 0000121667; Reuters: ESSI.PA; Bloomberg: EF.FP.

------------------------

Management Report

First-Half 2008

EUR millions First-half 2008 First-half 2007 % change

Revenue 1,520.2 1,476.9 +2.9%

Contribution from 276.3 267.3 +3.4%

operations (1)

18.2% 18.1%

% of revenue

Operating profit 261.7 253.2 +3.4%

Profit attributabl
'/>"/>

SOURCE Essilor
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Biopure Announces 2008 Third Quarter Financial Results
2. Kensey Nash Reports Fourth Quarter and Fiscal Year 2008 Results
3. CEL-SCI CORPORATION Reports Third Quarter 2008 Financial Results
4. Arpida Reports Interim Results for Six Months to 30 June 2008
5. Accuray Announces Results for the Fourth Quarter and Fiscal Year End 2008
6. Rosetta Genomics Reports Second Quarter 2008 Financial Results
7. VNUS Corrects Second Quarter 2008 Results and Revises Full Year 2008 Guidance
8. Arno Therapeutics Announces Second Quarter 2008 Financial Results
9. Logical Therapeutics Inc. Announces Results of Phase 1b Clinical Study of its Naproxen Prodrug
10. Lotus Pharmaceuticals Announces Second Quarter 2008 Results
11. Yongye Biotechnology International Announces Second Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... IRVINE, CA (PRWEB) , ... August 28, 2015 ... ... leader in Personalized Medicine, presented two studies at the International Spine Intervention ... on July 28th, 2015 through to August 1st, 2015. With a focus on ...
(Date:8/28/2015)... ... 2015 , ... Since the initial launch of FireflySci Inc. (FFS) in early 2015, the company ... Images such as the Fonz in a lab coat and Large Marge have been ... spectroscopy field. , FireflySci is proud to be the only cuvette manufacturer is ...
(Date:8/27/2015)... 2015 /PRNewswire/ - Portage Biotech Inc. ("Portage") (OTC ... Pharmaceutical Holding Company Limited (Biohaven), announced today that ... of BHV-0223, a glutamate modulating agent. Biohaven filed ... recently obtained clearance from the U.S. Food and ... Portage holds 54% equity interest in Biohaven, a ...
(Date:8/27/2015)... 27, 2015 HUYA Bioscience International (HUYA) today announced ... Japan Society of HTLV-1, held this week at the ... of the Society is to promote research on HTLV-1 ... medical technology and research related to these fields to ... "HUYA is proud to support this prestigious conference," said ...
Breaking Biology Technology:Proove Biosciences Presents New Research Study at the International Spine Intervention Society’s Annual Scientific Meeting 2Proove Biosciences Presents New Research Study at the International Spine Intervention Society’s Annual Scientific Meeting 3Proove Biosciences Presents New Research Study at the International Spine Intervention Society’s Annual Scientific Meeting 4Cuvette Manufacturer FireflySci Launches Back to School Deals with Complimentary Shipping On All Orders 2Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 2Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 3Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 4HUYA Bioscience International Sponsors Japan Society Of HTLV-1 Annual Meeting 2HUYA Bioscience International Sponsors Japan Society Of HTLV-1 Annual Meeting 3HUYA Bioscience International Sponsors Japan Society Of HTLV-1 Annual Meeting 4
... Imaging,Diagnostic Systems, Inc., (OTC Bulletin Board: ... systems, will exhibit CT Laser Mammography (CTLM(R)),technology ... Cancer,Conference, March 1-5, in Las Vegas, Nevada. ... (Logo: http://www.newscom.com/cgi-bin/prnh/20040412/IMDSLOGO ), "Attending ...
... SAN DIEGO, Feb. 27 NuVasive, Inc. (Nasdaq:,NUVA), a ... surgical treatments for the spine, announced today,that Kevin O,Boyle, ... present at the Canaccord Adams, Small-Cap Orthopedics,Conference at The ... on Tuesday, March 4, 2008 at 8:10 a.m. PT., ...
... Ocera Therapeutics, a,biopharmaceutical company focused on the ... a broad range of,gastrointestinal and liver diseases, announced ... company as Chief Medical Officer. Prior to joining,Ocera, ... Officer and Vice,President of Clinical Affairs at Napo ...
Cached Biology Technology:CT Laser Mammography Technology to be Featured at Interdisciplinary Breast Cancer Conference 2NuVasive to Present at Canaccord Adams' Small-Cap Orthopedics Conference 2NuVasive to Present at Canaccord Adams' Small-Cap Orthopedics Conference 3M. Scott Harris, M.D., Joins Ocera Therapeutics, Inc., as Chief Medical Officer 2
(Date:8/5/2015)... According to a new market research report, ... (BFSI, Airport, IT & Telecom, Utilities, Education, Defense & ... published by MarketsandMarkets, defines and segments the Physical Identity ... global PIAM Market is estimated to grow from $272.2 ... a CAGR of 14.9 % from 2014 to 2019. ...
(Date:8/3/2015)... 2015 Synaptics, Inc. (Nasdaq: SYNA ), ... that members of the executive management team will present ... Technology Leadership Forum on Tuesday, August 11, 2015 at ... at the Sonnenalp Resort in Vail, CO. ... forward-looking information. An audio webcast of the event will ...
(Date:7/31/2015)... 31 de julio de 2015 La 10 th ... celebrará por medio de BGI del 22 al 25 de octubre ... Este año, la conferencia celebra su décimo aniversario. ... convertido en una de las reuniones anuales más influyentes del ... las reuniones más dinámicas, entusiastas y mejores a nivel científico. ...
Breaking Biology News(10 mins):Physical Identity and Access Management Market Worth $546.2 Million by 2019 2Physical Identity and Access Management Market Worth $546.2 Million by 2019 3Physical Identity and Access Management Market Worth $546.2 Million by 2019 4La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 2La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 3
... major research findings at the 11th International Coral Reef Symposium ... African Dust Poses Threat to Coral Reefs and Human ... Caribbean and the Americas may be a threat to marine ... study by researchers with the U.S. Geological Survey, Oregon State ...
... Researchers from Harvard Medical School and Brandeis University have ... what types of genes are necessary for brain development. ... are published July 4th in the open-access journal PLoS ... sequencing of entire genomes and the discovery of RNA-interference ...
... the biggest challenges facing humanity is to halt the destruction ... task that must be urgently addressed and in which we ... is our duty to do all we can for the ... researchers Harold Mooney and Peter Raven, regarded as the architects ...
Cached Biology News:The good, the bad and the smelly: USGS at the 2008 Coral Reef Symposium 2The good, the bad and the smelly: USGS at the 2008 Coral Reef Symposium 3The good, the bad and the smelly: USGS at the 2008 Coral Reef Symposium 4The good, the bad and the smelly: USGS at the 2008 Coral Reef Symposium 5The good, the bad and the smelly: USGS at the 2008 Coral Reef Symposium 6The good, the bad and the smelly: USGS at the 2008 Coral Reef Symposium 7The good, the bad and the smelly: USGS at the 2008 Coral Reef Symposium 8The good, the bad and the smelly: USGS at the 2008 Coral Reef Symposium 9Researchers reveal types of genes necessary for brain development 2BBVA Foundation Awards for Biodiversity Conservation 2BBVA Foundation Awards for Biodiversity Conservation 3BBVA Foundation Awards for Biodiversity Conservation 4
NATIVE, ENZYME PORCINE TRYPSIN...
G-Protein Coupled Receptor Assay, For 500 assays. SPA. Category: Drug Screening & Cellular Assays, Assays ....
EDTA, disodium salt, 1 kg. Ethylene diaminetetraacetic acid.Dihydrate. Assay: 99.0-101.0%, nuclease-free.Risks: 36, 37, 38 ; Safety Precautions: 22, 36, 37. Category: Nucleotides & Enzymes & Biochemi...
Alkaline Phosphatase Stabilizer Solution, 1 L...
Biology Products: